Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada
- Sales of Year 1 expected at US$6 million - Projected to increase to US$12 million in Year 2 and US$25 million in Year 3 - Supported by Diabetes Canada and the Glycemic Index Foundation - Patented "Clean Label" Ingredients - Company plans to attack Instant Noodle market
Perth, Kuala Lumpur and Ontario, Feb 14, 2018 - (ACN Newswire) - Holista CollTech Ltd ("Holista")(ASX: HCT) is pleased to announce group company Holista Foods Inc. ("HolistaFoods") has signed a 3-year MoU to supply its patented low glycemic index ("GI") mix to Wing's Group, North America's leading noodle supplier.
Pursuant to the MoU, sales are expected to be US$6 million for the 2018 financial year. This is projected to increase to US$12 million in 2019 and to US$25 million in 2020.
The MoU with Ontario-based Wing's is the first order for Holista which seeks to address obesity and diabetes-related health issues worldwide with this technology offering. According to the Center for Disease Control and Prevention, over 100 million adult Americans suffer from diabetes or pre-diabetes.
The sales order marks HolistaFoods' entry into the billion-dollar global noodle market. According to Grand View Research, the global pasta and noodles market size was valued at USD 59.6 billion in 2016 and is expected to grow at a compounded annual rate of 3.6%. The U.S. noodle market alone is worth US$270 million, the world's sixth largest market for instant noodles. In 2016, the World Instant Noodles Association reported 97.5 billion servings consumed around the world.
Noodles account for half the world's supply of wheat compared to 25% for bread.
Developed by HolistaFoods Buffalo, the New York-based arm of Holista Foods Inc., and supported by Diabetes Canada, the patented formula recorded a GI reading of 38 in independent tests by Glycemic Index Laboratories, Inc., well below the global average of 60. The reading indicates the rate in which foods containing carbohydrates raise human blood sugar levels, with a lower score indicating healthier food.
The noodles are endorsed by the Glycemic Index Foundation and follow the guidelines and recommendations of Diabetes Canada.
An 85-gram serving of noodles contains 11 grams of protein, three grams of fibre, zero sugar while being low sodium and cholesterol and provides sustained energy. The noodles cook in just three minutes.
HolistaFoods formula comprises extracts of okra (ladies' fingers), lentils, barley and fenugreek - clean label ingredients - all natural, with no artificial ingredients or preservatives.
This has successfully tested low-GI formulas for bread and muffins, and is now working on mixes for pasta and pancakes. A key feature is that the mix can be prepared easily, with no discernible change in taste or texture of the finished product.
The order from Wing's is expected to have a significant impact on Holista's revenue from the financial year ending 31 December 2018.
Neal Lee, President of Wing's, said: "Diabetes is becoming a global pandemic that threatens lives and increases healthcare costs. Wing's is proud to be the first major noodle manufacturer in the world to launch a dedicated low-GI noodle. We are confident that our partnership with Holista will be well-received in North America, if not globally."
Nadja Piatka, CEO of Holista Foods, said: "The North American noodle market is sizeable and significant, and we believe this collaboration with Wing's can set the trend for global acceptance of a healthy version of instant noodles without compromising taste or texture. We are grateful to Wing's for this partnership."
Dr Rajen Manicka, Chairman and CEO of Holista, said: "Our MoU with Wing's is significant as it marks our entry into the global noodle market with a low-GI product that is both healthy and affordable. We are confident that this market validation will also enable us to gain greater acceptance in Asia, especially in the leading noodle markets of China and Indonesia. We now want to make a push in the lucrative instant noodle market."
About Holista CollTech Ltd
Holista CollTech Ltd ("Holista") is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products and leads in research on herbs and food ingredients.
Holista, listed on the Australia Securities Exchange, researches, develops, manufactures and markets "health-style" products to address the unmet and growing needs of natural medicine. Holista's suite of ingredients is capable of serving the industry to provide low-GI baked products, low sodium salt, low fat fried foods and low calories sugar without compromise in taste, odour and mouth feel. It is the only company to produce sheep (ovine) collagen using patented extraction methods.
About Holista Foods Inc
HolistaFoods is an American joint venture between Holista Colltech and Nadja Foods to commercialize all its patents in North America. For more information, visit: www.holistafoods.com
About Wing's Food Products
Wing's Food Products ("Wing's") is a family business founded in 1953 that began supplying noodles, wraps and sauces to the Asian restaurant industry and has grown to become a major Canadian manufacturer of noodles, wraps and cookies to retail, food service and B2B with operations in Toronto, Ontario and Edmonton, Alberta. For more information, please visit: www.wings.ca
For further information, please contact:
Corporate Affairs & Business Opportunities Dr Rajen Manicka: rajen.m@holistaco.com General Enquiries: enquiries@holistaco.com
Australia 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500; F: +61 8 6141 3599
Malaysia 12th Floor, Amcorp Trade Centre, PJ Tower No. 18, Persiaran Barat off Jalan Timur 46000, Petaling Jaya, Malaysia P: +603 7965 2828 ; F: +603 7965 2777
Media and Investor Relations Enquiries WeR1 Consultants Pte Ltd 3 Phillip Street #12-01 Singapore 048693 Asha Devi, ashadevi@wer1.net; P: +603 2731 9244 Roshan Singh, roshansingh@wer1.net; P: +65 67374844
Source: Holista Foods Inc. Sectors: Food & Beverage, BioTech, Healthcare & Pharm, Cosmetics, Spec.Chem
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Hitachi High-Tech Launches DCR Etch System 9060 Series, Supporting Isotropic Etching of Advanced 3D Devices at the Atomic Level Nov 28, 2024 11:31 JST
| MHI Delivers Final Trainset of Automated Guideway Transit System "2020 Series" to Saitama New Urban Transit Nov 28, 2024 10:08 JST
| TOPVISION Launches Prospectus for Listing Transfer from LEAP to the ACE Market Nov 27, 2024 05:53 JST
| TOYOTA GAZOO Racing FULLY PREPARED FOR DAKAR 2025 Nov 26, 2024 17:55 JST
| Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan Nov 26, 2024 15:50 JST
| Fujitsu develops Policy Twin, a new digital twin technology to maximize effectiveness of local government policies for solving societal issues Nov 26, 2024 10:51 JST
| TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025 Nov 25, 2024 17:10 JST
| Toyota Submits Progress Report on Recurrence Prevention Measures Nov 25, 2024 15:43 JST
| TOPVISION Launches Prospectus for Transfer Listing from LEAP to the ACE Market Nov 25, 2024 15:00 JST
| MHI Thermal Systems Receives Order from Aisan Industry for Aquifer Thermal Energy Storage System for Its New Anjo Plant Nov 25, 2024 14:18 JST
| Oracle Red Bull Racing Driver Max Verstappen Wins Fourth Consecutive F1 Drivers' World Championship Nov 25, 2024 11:55 JST
| Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025 Nov 22, 2024 11:00 JST
| NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth Nov 21, 2024 22:59 JST
| Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan Nov 21, 2024 15:35 JST
| Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP Nov 21, 2024 09:00 JST
| ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study Nov 20, 2024 23:05 JST
| Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center Nov 20, 2024 15:30 JST
| Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Nov 20, 2024 11:51 JST
| Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Nov 20, 2024 10:24 JST
| Kingsoft Announces 2024 Third Quarter Results Nov 19, 2024 18:54 JST
|
More Latest Release >>
|